• About
• Links
• Contact
• Sitemap
• 

The Worldwide Market for Prescription Dermatological Drugs - 4th Edition

This report provides the reader with a comprehensive analysis of the US and international markets involving pharmaceuticals to treat skin diseases and disorders. 

This report evaluates the market from the ground up interviewing industry participants, clinicians, and regulators.

Market information is available for the years 1998 to 2008, with the focus year 2003. Overview and product descriptions of general adjunctive therapy segments are covered, including prescription drugs to treat:

• Acne and Rosacea
• Antiaging and Photodamage
• Dermatitis and Seborrhea
• Fungal Infections
• Hair Loss and Hair Removal
• Hyperpigmentation/Melasma
• Psoriasis
• Skin Cancer , and
• Other Skin Disorders

Other data points include competitive market share, demographics, epidemiology, and geographic break down. The study covers issues and trends affecting the market, research and developments, and more. In particular, the study explores the current and potential effects of the aging baby boomers on the prescription dermatology market and the continued demand for lifestyle drugs. Profiles of major market participants are included.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

• Scope and Methodology
• Size and Growth of the Market
• Issues and Trends Affecting Market
• Competitor Analysis

CHAPTER TWO: INTRODUCTION

• Structure and Function of the Skin
  • Epidermis
  • Dermis
  • Subcutaneous Tissue
  • Epidermal Appendages
• Functions of the Skin
• Effects of Aging on the Skin
• Dermatological Conditions and Treatment
• Pharmacokinetics
  • Drug Absorption
  • Distribution
  • Bioavailability
• Drug Delivery Methods
• Demographics of Skin Disorders, Incidence, and Prevalence

CHAPTER THREE: ISSUES AND TRENDS

• Cosmetic Dermatologists
• New Filler Options
• A Confusing Industry
• Genetic Link to Psoriasis
• Biologic Dermatology
• Rx-to-OTC Switches
• Cosmeceuticals
• Teledermatology
• Reimbursement Issues
• Laser Therapy
• Narrowband Ultraviolet B
• Photodynamic Therapy
• Importance of Drug Delivery

CHAPTER FOUR: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS

• Description of Disorders
• Description of Products
  • Benzoyl Peroxide
  • Retinoids
  • Antibiotics
  • Oral Contraceptives
• Research and Development
• Market Size and Growth
  • Global Market
  • Markets by Geographical Region
• The Future of the Market
• Competitive Analysis

CHAPTER FIVE: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS

• Overview
• Description of Products
  • Keratolytics
  • Moisturizers
  • Retinoids
  • Sunscreens
  • Other Agents
• Research and Development
• Market Size and Growth
  • Global Market
  • Markets by Geographical Region
• The Future of the Market
• Competitive Analysis

CHAPTER SIX: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS

• Overview
• Description of Products
  • Topical Corticosteroids
  • Systemic Corticosteroids
  • Other Products
• Research and Development
• Market Size and Growth
  • Global Market by Type
  • Markets by Geographical Region
• Future of the Market
• Competitive Analysis

CHAPTER SEVEN: PRESCRIPTION ANTIFUNGAL DRUGS

• Overview
• Description of Products
  • Systemic Formulations
  • Topical Formulations
• Research and Development
• Market Size and Growth
  • Global Market by Type
  • Markets by Geographical Region
• Future of the Market
• Competitive Analysis

CHAPTER EIGHT: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS

• Overview
• Description of Products
  • Antiandrogens
  • Androgen Inhibitors
  • Oral Contraceptives
  • Other Treatments
• Research and Development
• Market Size and Growth
  • Global Market by Type
  • Markets by Geographical Region
• Future of the Market
• Competitive Analysis

CHAPTER NINE: PRESCRIPTION HYPERPIGMENTATION/MELASMA DRUGS

• Overview
• Description of Products
• Research and Development
• Market Size and Growth
  • Global Market
  • Markets by Geographical Region
• The Future of the Market
• Competitive Analysis

CHAPTER TEN: PRESCRIPTION PSORIASIS DRUGS

• Overview
• Description of Products
  • Topical Psoriasis Products
  • Systemic Psoriasis Preparations
• Research and Development
• Market Size and Growth
  • Global Market by Type
  • Markets by Geographical Region
• Future of the Market
• Competitive Analysis

CHAPTER ELEVEN: PRESCRIPTION SKIN CANCER DRUGS

• Overview
  • Nonmelanoma Skin Cancers
  • Malignant Melanoma
• Description of Products
  • 5-Fluorouracil
  • Mechlorethamine/Nitrogen Mustard
  • Carmustine/BCNU (Topical)
  • Vinblastine (Intralesional) and Others
• Research and Development
• Market Size and Growth
  • Global Market
  • Markets by Geographical Region
• The Future of the Market
• Competitive Analysis

CHAPTER TWELVE: MISCELLANEOUS SKIN DISORDER DRUGS—ANTIVIRALS AND ANTIPARASITICS

• Overview
  • Antivirals
  • Antiparasitics
• Description of Products
  • Topical Antivirals
  • Antiparasitic Agents
• Research and Development
• Market Size and Growth
  • Global Market
  • Markets by Geographical Region
• The Future of the Market
• Competitive Analysis

CHAPTER THIRTEEN: WORLD MARKET SUMMARY

• Overview
• Total Market Size and Forecast
• Market and Competitive Analysis

CHAPTER FOURTEEN: CORPORATE PROFILES

•  
• Bayer AG
• Bertek Pharmaceuticals, Inc.
• Bristol-Myers Squibb
• Galderma S.A.
• Genentech, Inc.
• GlaxoSmithKline Plc
• Inamed Corporation
• Johnson & Johnson, Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil
• Medicis Pharmaceutical Corporation
• Merck & Company, Inc.
• Novartis Pharmaceuticals Corporation
• Pfizer, Inc
• Q-Med AB
• Roche Group (F. Hoffmann-La Roche Ltd.)
• Schering-Plough Corporation
• Valeant Pharmaceuticals, Inc

APPENDIX: COMPANY DIRECTORY
LIST OF EXHIBITS

 

CHAPTER ONE: EXECUTIVE SUMMARY

• Table 1-1: The Global Market for Prescription Dermatological Drugs 1998, 2003, and 2008
• Figure 1-1: The Global Market for Prescription Dermatological Drugs 1998, 2003, and 2008

CHAPTER TWO: INTRODUCTION

• Table 2-1: Common Bases for Topical Dermatological Medications
• Table 2-2: Worldwide Incidence and Prevalence of Selected Dermatologic Conditions

CHAPTER THREE: ISSUES AND TRENDS

• Table 3-1: Selected Dermatological Rx-to-OTC Switches
• Table 3-2: Selected Potential Prescription Dermatological Rx-to-OTC Switches

CHAPTER FOUR: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS

• Table 4-1: Common Benzoyl Peroxide Formulations
• Table 4-2: Common Retinoid Formulations
• Table 4-3: Common Antibiotic Formulations
• Table 4-4: Common Oral Contraceptive Formulations
• Table 4-5: Prescription Acne and Rosacea Formulations in Development
• Table 4-6: The Global Market for Prescription Acne and Rosacea Drugs by Type 1998-2008
• Figure 4-1: The Global Market for Prescription Acne and Rosacea Drugs Revenues by Type 1998-2008
• Table 4-7: The Global for Prescription Acne and Rosacea Drugs, Market Share by Type 1998-2008
• Figure 4-2: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2003
• Figure 4-3: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2008
• Table 4-8: The Global Market for Prescription Antiacne and Rosacea Drugs by Geographical Region 1998-2008
• Figure 4-4: The Global Market for Prescription Antiacne and Rosacea Drugs Revenues by Geographical Region 1998-2008
• Table 4-9: The Global for Prescription Antiacne and Rosacea Drugs Market Share by Geographical Region 1998-2008
• Figure 4-5: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2003
• Figure 4-6: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2008
• Table 4-10: The U.S. Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
• Figure 4-7: The U.S. Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
• Table 4-11: The European Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
• Figure 4-8: The European Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
• Table 4-12: The Japanese Market for Prescription Acne and RosaceaDrugs Manufacturer Revenues 1998-2008
• Figure 4-9: The Japanese Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
• Table 4-13: The Rest of World Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
• Figure 4-10: The Rest of World Market for Prescription Acne and Rosacea Drugs Manufacturer Revenues 1998-2008
• Table 4-14: Global Market for Prescription Antiacne and Rosacea Drugs Revenues and Market Share by Supplier 2003
• Figure 4-11: Global Market for Acne and Rosacea Drugs Market Share by Leading Supplier 2003

CHAPTER FIVE: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS

• Table 5-1: Common Prescription Keratolytic Formulations
• Table 5-2: Occlusive Moisturizers—Categories of Ingredients
• Table 5-3: Common Prescription Moisturizers
• Table 5-4: Common Prescription Retinoids for Antiaging and Photodamage
• Table 5-5: Common Prescription Sunscreens
• Table 5-6: Prescription Other Antiaging and Photodamage Products
• Table 5-7: Prescription Antiaging and Photodamage Formulations in Development
• Table 5-8: The Global Market Antiaging and Photodamage Drugs by Type 1998-2008
• Figure 5-1: The Global Market for Antiaging and Photodamage Drugs Revenues by Type 1998-2008
• Table 5-9: The Global for Antiaging and Photodamage Drugs Market Share by Type 1998-2008
• Figure 5-2: The Global Market for Antiaging and Photodamage Drugs Share by Type 2003
• Figure 5-3: The Global Market for Antiaging and Photodamage Drugs Share by Type 2008
• Table 5-10: The Global Market for Prescription Antiaging and Photodamage Drugs by Geographical Region 1998-2008
• Figure 5-4: The Global Market for Prescription Antiaging and Photodamage Drugs Revenues by Geographical Region 1998-2008
• Table 5-11: The Global Market for Prescription Antiaging and Photodamage Drugs Market Share by Geographical Region 1998-2008
• Figure 5-5: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2003
• Figure 5-6: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2008
• Table 5-12: The U.S. Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
• Figure 5-7: The U.S. Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
• Table 5-13: The European Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
• Figure 5-8: The European Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
• Table 5-14: The Japanese Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
• Figure 5-9: The Japanese Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
• Table 5-15: The Rest of World Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
• Figure 5-10: The Rest of World Market for Prescription Antiaging and Photodamage Drugs Manufacturer Revenues 1998-2008
• Table 5-16: Global Market for Prescription Antiaging and Photodamage Drugs Revenues and Market Share by Supplier 2003
• Figure 5-11: Global Market for Prescription Antiaging and Photodamage Drugs Market Share by Leading Supplier 2003

CHAPTER SIX: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS

• Table 6-1: Common Prescription Topical Corticosteroid Preparations
• Table 6-2: Common Prescription Systemic Corticosteroids
• Table 6-3: Prescription Dermatitis Formulations in Development
• Table 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Type 1998-2008
• Figure 6-1: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Type 1998-2008
• Table 6-5: The Global Market for Prescription Dermatitis and Seborrhea Drugs Market Share by Type 1998-2008
• Figure 6-2: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2003
• Figure 6-3: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2008
• Table 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Geographical Region 1998-2008
• Figure 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Geographical Region 1998-2008133
• Table 6-7: The Global Market for Prescription Dermatitis and Seborrhea Drugs Market Share by Geographical Region 1998-2008
• Figure 6-5: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2003
• Figure 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2008
• Table 6-8: The U.S. Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
• Figure 6-7: The U.S. Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
• Table 6-9: The European Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
• Figure 6-8: The European Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
• Table 6-10: The Japanese Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
• Figure 6-9: The Japanese Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
• Table 6-11: The Rest of World Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
• Figure 6-10: The Rest of World Market for Prescription Dermatitis and Seborrhea Drugs Manufacturer Revenues 1998-2008
• Table 6-12: Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues and Market Share by Supplier 2003
• Figure 6-11: Global Market for Prescription Dermatitis and Seborrhea Drugs Market Share by Leading Supplier 2003

CHAPTER SEVEN: PRESCRIPTION ANTIFUNGAL DRUGS

• Table 7-1: Common Prescription Systemic Antifungal Dermatological Formulations
• Table 7-2: Common Prescription Topical Antifungal Dermatological Drugs
• Table 7-3: Prescription Antifungal Dermatological Drugs in Development
• Table 7-4: The Global Market for Prescription Antifungal Dermatological Drugs by Type 1998-2008
• Figure 7-1: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Type 1998-2008
• Table 7-5: The Global for Prescription Antifungal Dermatological Drugs Market Share by Type 1998-2008
• Figure 7-2: The Global Market for Prescription Antifungal Dermatological Drugs Share by Type 2003
• Figure 7-3: The Global Market for Prescription Antifungal Dermatological Drugs Share by Type 2008
• Table 7-6: The Global Market for Prescription Antifungal Dermatological Drugs by Geographical Region 1998-2008
• Figure 7-4: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Geographical Region 1998-2008
• Table 7-7: The Global Market for Prescription Antifungal Dermatological Drugs Market Share by Geographical Region 1998-2008
• Figure 7-5: The Global Market for Prescription Antifungal Dermatological Drugs Share by Geographical Region 2003
• Figure 7-6: The Global Market for Prescription Antifungal Dermatological Drugs Share by Geographical Region 2008
• Table 7-8: The U.S. Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
• Figure 7-7: The U.S. Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
• Table 7-9: The European Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
• Figure 7-8: The European Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
• Table 7-10: The Japanese Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
• Figure 7-9: The Japanese Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
• Table 7-11: The Rest of World Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
• Figure 7-10: The Rest of World Market for Prescription Antifungal Dermatological Drugs Manufacturer Revenues 1998-2008
• Table 7-12: Global Market for Prescription Antifungal Dermatological Drugs Revenues and Market Share by Supplier 2003
• Figure 7-11: Global Market for Prescription Antifungal Dermatological Drugs Market Share by Leading Supplier 2003

CHAPTER EIGHT: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS

• Table 8-1: Common Prescription Hair Loss or Hair Removal Formulations
• Table 8-2: Prescription Hair Loss or Hair Removal Formulations in Development
• Table 8-3: The Global Market for Prescription Hair Loss and Hair Removal Drugs by Type 1998-2008
• Figure 8-1: The Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues by Type 1998-2008
• Table 8-4: The Global Market for Prescription Hair Loss and Hair Removal Drugs Market Share by Type 1998-2008
• Figure 8-2: The Global Market for Prescription Hair Loss and Hair Removal Drugs Share by Type 2003
• Figure 8-3: The Global Market for Prescription Hair Loss and Hair Removal Drugs Share by Type 2008
• Table 8-5: The Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues by Geographical Region 1998-2008
• Figure 8-4: The Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues by Geographical Region 1998-2008
• Table 8-6: The Global Market for Prescription Hair Loss and Hair Removal Drugs Market Share by Geographical Region 1998-2008
• Figure 8-5: The Global Market for Prescription Hair Loss and Hair Removal Drugs Share by Geographical Region 2003
• Figure 8-6: The Global Market for Prescription Hair Loss and Hair Removal Drugs Share by Geographical Region 2008
• Table 8-7: The U.S. Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
• Figure 8-7: The U.S. Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
• Table 8-8: The European Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
• Figure 8-8: The European Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
• Table 8-9: The Japanese Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
• Figure 8-9: The Japanese Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
• Table 8-10: The Rest of World Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
• Figure 8-10: The Rest of World Market for Prescription Hair Loss and Hair Removal Drugs Manufacturer Revenues 1998-2008
• Table 8-11: Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues and Market Share by Supplier 2003
• Figure 8-11: Global Market for Prescription Hair Loss and Hair Removal Drugs Market Share by Leading Supplier 2003

CHAPTER NINE: PRESCRIPTION HYPERPIGMENTATION/MELASMA DRUGS

• Table 9-1: Common Prescription Hyperpigmentation/Melasma Formulations
• Table 9-2: Common Prescription Depigmenting Agents
• Table 9-3: The Global Market for Hyperpigmentation/Melasma Drugs by Type 1998-2008
• Figure 9-1: The Global Market for Hyperpigmentation/Melasma Drugs Revenues by Type 1998-2008
• Table 9-4: The Global for Prescription Hyperpigmentation/Melasma Drugs, Market Share by Type 1998-2008
• Figure 9-2: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Type 2003
• Figure 9-3: The Global Market for Prescription Hyperpigmentation/Melasma Drugs Share by Type 2008
• Table 9-5: The Global Market for Prescription Hyperpigmentation/Melasma Drugs by Geographical Region 1998-2008
• Figure 9-4: The Global Market for Prescription Hyperpigmentation/Melasma Drugs Revenues by Geographical Region 1998-2008
• Table 9-6: The Global Market for Prescription Hyperpigmentation/Melasma Drugs Market Share by Geographical Region 1998-2008
• Figure 9-5: The Global Market for Prescription Hyperpigmentation/Melasma Drugs, Share by Geographical Region 2003
• Figure 9-6: The Global Market for Prescription Hyperpigmentation/Melasma Drugs, Share by Geographical Region 2008
• Table 9-7: The U.S. Market for Prescription Hyperpigmentation/Melasma Drugs Manufacturer Revenues 1998-2008
• Figure 9-7: The U.S. Market for Prescription Hyperpigmentation/Melasma Drugs Manufacturer Revenues 1998-2008
• Table 9-8: The European Market for Prescription Hyperpigmentation/Melasma Drugs Manufacturer Revenues 1998-2008
• Figure 9-8: The European Market for Prescription Hyperpigmentation/Melasma Drugs Manufacturer Revenues 1998-2008
• Table 9-10: The Japanese Market for Prescription Hyperpigmentation/Melasma Drugs Manufacturer Revenues 1998-2008
• Figure 9-10: The Japan Market for Prescription Hyperpigmentation/Melasma Drugs Manufacturer Revenues 1998-2008
• Table 9-11: The Rest of World Market for Prescription Hyperpigmentation/Melasma Drugs Manufacturer Revenues 1998-2008
• Figure 9-11: The Rest of World Market for Prescription Hyperpigmentation/Melasma Drugs Manufacturer Revenues 1998-2008

CHAPTER TEN: PRESCRIPTION PSORIASIS DRUGS

• Table 10-1: Common Prescription Psoriasis Preparations
• Table 10-2: Prescription Psoriasis Preparations in Development
• Table 10-3: The Global Market for Prescription Psoriasis Drugs by Type 1998-2008
• Figure 10-1: The Global Market for Prescription Psoriasis Drugs Revenues by Type 1998-2008
• Table 10-4: The Global Market for Prescription Psoriasis Drugs Market Share by Type 1998-2008
• Figure 10-2: The Global Market for Prescription Psoriasis Drugs Share by Type 2003
• Figure 10-3: The Global Market for Prescription Psoriasis Drugs Share by Type 2008
• Table 10-5: The Global Market for Prescription Psoriasis Drugs by Geographical Region 1998-2008
• Figure 10-4: The Global Market for Prescription Psoriasis Drugs Revenues by Geographical Region 1998-2008
• Table 10-6: The Global Market for Prescription Psoriasis Drugs Market Share by Geographical Region 1998-2008
• Figure 10-5: The Global Market for Prescription Psoriasis Drugs Share by Geographical Region 2003
• Figure 10-6: The Global Market for Prescription Psoriasis Drugs Share by Geographical Region 2008
• Table 10-7: The U.S. Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
• Figure 10-7: The U.S. Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
• Table 10-8: The European Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
• Figure 10-8: The European Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
• Table 10-9: The Japanese Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
• Figure 10-9: The Japanese Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
• Table 10-10: The Rest of World Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
• Figure 10-10: The Rest of World Market for Prescription Psoriasis Drugs Manufacturer Revenues 1998-2008
• Table 10-11: Global Market for Prescription Psoriasis Drugs Revenues and Market Share by Supplier 2003
• Figure 10-11: Global Market for Prescription Psoriasis Drugs Market Share by Leading Supplier 2003

CHAPTER ELEVEN: PRESCRIPTION SKIN CANCER DRUGS

• Table 11-1: Malignant Conditions of the Skin
• Table 11-2: Common Prescription Topical and Intralesional Chemotherapeutic Agents
• Table 11-3: Prescription Skin Cancer Preparations in Development
• Table 11-4: The Global Market for Skin Cancer Drugs 1998-2008
• Figure 11-1: The Global Market for Skin Cancer Drugs 1998-2008
• Table 11-5: The Global Market for Prescription Skin Cancer Drugs by Geographical Region 1998-2008
• Figure 11-2: The Global Market for Prescription Skin Cancer Drugs Revenues by Geographical Region 1998-2008
• Table 11-6: The Global for Prescription Skin Cancer Drugs Market Share by Geographical Region 1998-2008
• Figure 11-3: The Global Market for Prescription Skin Cancer Drugs Share by Geographical Region 2003
• Figure 11-4: The Global Market for Prescription Skin Cancer Drugs Share by Geographical Region 2008
• Table 11-7: The U.S. Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
• Figure 11-5: The U.S. Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
• Table 11-8: The European Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
• Figure 11-6: The European Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
• Table 11-9: The Japanese Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
• Figure 11-7: The Japanese Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
• Table 11-10: The Rest of World Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
• Figure 11-8: The Rest of World Market for Prescription Skin Cancer Drugs Manufacturer Revenues 1998-2008
• Table 11-12: Global Market for Prescription Skin Cancer Drugs Revenues and Market Share by Supplier 2003
• Figure 11-9: Global Market for Skin Cancer Drugs Market Share by Leading Supplier 2003

CHAPTER TWELVE: MISCELLANEOUS SKIN DISORDER DRUGS—ANTIVIRALS AND ANTIPARASITICS

• Table 12-1: Common Prescription Topical Antiviral Formulations
• Table 12-2: Common Prescription Topical Antiparasitic Formulations
• Table 12-3: The Global Market for Prescription Miscellaneous Skin Disorder Drugs by Type 1998-2008
• Figure 12-1: The Global Market for Miscellaneous Skin Disorder Drugs Revenues by Type 1998-2008
• Table 12-4: The Global Market for Prescription Miscellaneous Skin Disorder Drugs Market Share by Type 1998-2008
• Table 12-5: The Global Market for Prescription Miscellaneous Drugs by Geographical Region 1998-2008
• Figure 12-2: The Global Market for Prescription Miscellaneous Drugs Revenues by Geographical Region 1998-2008
• Table 12-6: The Global for Prescription Miscellaneous Drugs Market Share by Geographical Region 1998-2008
• Figure 12-3: The Global Market for Prescription Miscellaneous Drugs Share by Geographical Region 2003
• Figure 12-6: The Global Market for Prescription Miscellaneous Drugs Share by Geographical Region 2008
• Table 12-7: The U.S. Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
• Figure 12-5: The U.S. Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
• Table 12-8: The European Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
• Figure 12-6: The European Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
• Table 12-9: The Japanese Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
• Figure 12-7: The Japanese Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
• Table 12-10: The Rest of World Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008
• Figure 12-8: The Rest of World Market for Prescription Miscellaneous Drugs Manufacturer Revenues 1998-2008

CHAPTER THIRTEEN: WORLD MARKET SUMMARY

• Table 13-1: The Global Market for Prescription Dermatological Drugs, Revenues by Segment, 1998-2008
• Figure 13-1: The Global Market for Prescription Dermatological Drugs, Revenues by Dermatological Segment, 1998-2008
• Table 13-2: The Global for Prescription Dermatological Drugs Market Share by Dermatological Segment 1998-2008
• Figure 13-2: The Global Market for Dermatological Drugs Market Share by Type 2003
• Figure 13-3: The Global Market for Prescription Dermatological Drugs Market Share by Type 2008
• Table 13-3: Global Market for Prescription Dermatological Drugs Revenues and Segments of Participation by Leading Market Participants 2003

   

Other users found this report page using the following search terms: Acne Rosacea Dermatitis Seborrhea Melasma Psoriasis Skin Cancer melanoma market size drugs dermatology prescription dermatological hair acne share 2008

If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.

Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.